| NCT Number | NCT07442630 |
| Lead Sponsor | JW Pharmaceutical |
| Conditions | Hypercholesterolemia |
| Enrollment | 88 participants |
| Start Date | 2023-08-21 |
| Primary Completion | 2026-01-22 (estimated) |
| Study Completion | 2026-11-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-02 |